What Is X-Ray Crystallography?
X-ray crystallography is the most powerful method for determining the three-dimensional arrangement of atoms in a solid material at atomic resolution. By analyzing the pattern of X-rays diffracted by a crystal, scientists can determine bond lengths, bond angles, and the complete three-dimensional coordinates of every atom in a molecule with angstrom-level precision (1 Å = 10⁻¹⁰ m).
Since its development in 1913 by William and Lawrence Bragg (who shared the 1915 Nobel Prize in Physics), X-ray crystallography has been central to some of the most important discoveries in science: the double helix structure of DNA (1953), the first protein structure (myoglobin, 1958), penicillin's structure (Dorothy Hodgkin, 1945), and the structures of thousands of pharmaceutical drug targets enabling rational drug design.
The Physics: Bragg's Law
Crystals consist of atoms arranged in a regular, repeating three-dimensional lattice. When X-rays (wavelength λ ≈ 0.1–2.5 Å) strike the crystal, they scatter off electrons associated with atoms in successive parallel planes of the lattice.
Bragg's Law describes the condition for constructive interference (diffraction):
nλ = 2d sin θ
Where: - n = integer (order of reflection) - λ = X-ray wavelength - d = spacing between crystal planes (lattice spacing) - θ = angle of incidence (Bragg angle)
When Bragg's condition is satisfied, scattered waves from successive planes are exactly in phase, producing an intense diffracted beam. At all other angles, waves cancel by destructive interference. The collection of all diffracted beams produces a diffraction pattern of spots — a map in reciprocal space of the crystal's internal structure.
From Crystal to Structure: The Phase Problem
Determining a crystal structure involves two steps:
1. Data Collection
A crystal is mounted and exposed to an X-ray beam (from a laboratory rotating anode source or a synchrotron). The crystal is rotated through many orientations while a detector records the position and intensity of thousands of diffraction spots. Modern area detectors (CCD or pixel array) collect complete datasets in minutes to hours.
2. Structure Solution: The Phase Problem
From diffraction data, the intensity I_hkl of each reflection (indexed by Miller indices h, k, l) can be measured directly. The structure factor F_hkl relates to the atomic positions:
F_hkl = Σ_j f_j exp(2πi(hx_j + ky_j + lz_j))
where f_j is the scattering factor of atom j and (x_j, y_j, z_j) are its fractional coordinates.
The electron density ρ(x,y,z) — which reveals where atoms are — is the Fourier transform of the structure factors. The problem: we can measure |F_hkl| from intensities (|F|² = I), but not the phase of each F, which is also needed for the transform. This is the phase problem, the central challenge of crystallography.
Common solutions: - Direct methods: Statistical methods exploiting constraints from known relationships between phases; standard for small molecules - Molecular replacement (MR): Using a known similar structure as a search model; standard for proteins - Anomalous dispersion (SAD/MAD): Heavy atom phasing using the anomalous scattering of selenium or other heavy atoms at specific X-ray energies - Isomorphous replacement (MIR): Comparing diffraction from native crystals and heavy-atom-soaked crystals
3. Structure Refinement
An initial model is iteratively adjusted by least-squares refinement — minimizing the difference between observed and calculated structure factors. Convergence is assessed by the R-factor:
R = Σ||F_obs| − |F_calc|| / Σ|F_obs|
A good small-molecule structure has R < 5%; protein structures typically achieve R < 20% with R_free (cross-validation against unused data) < 25%.
Crystal Growth
The technique depends entirely on growing single crystals of sufficient size and quality. This is often the most challenging step. Crystals are grown by: - Slow evaporation: Dissolving in solvent and allowing slow evaporation - Vapor diffusion: Placing drop of protein solution against a reservoir of precipitant; water vapor slowly equilibrates (hanging-drop or sitting-drop method) - Temperature change: Cooling a supersaturated solution - Antisolvent precipitation: Adding a non-solvent to reduce solubility
For proteins, crystallization conditions (pH, salt, precipitant type, temperature) are screened combinatorially across 96-well plates.
Powder Diffraction
When single crystals cannot be grown, powder X-ray diffraction (PXRD) analyzes a polycrystalline powder. The randomly oriented microcrystals produce rings (Debye-Scherrer rings) rather than spots. PXRD provides: - Phase identification (fingerprint matching to databases) - Lattice parameters and unit cell dimensions - Crystal size (Scherrer equation) - Quantitative phase analysis (Rietveld refinement)
PXRD is routine in pharmaceutical solid-state analysis (polymorph identification), materials science (alloy phase diagrams), and geology (mineral identification).
Synchrotron X-Ray Sources
Modern macromolecular crystallography uses synchrotrons — particle accelerators that produce X-rays 10¹⁰ times brighter than laboratory sources. Synchrotron radiation enables: - Data collection from tiny crystals (10–50 μm) - Tunable wavelength for anomalous dispersion phasing - Time-resolved studies of enzyme catalysis - Micro-focus beams for membrane protein crystals
Serial femtosecond crystallography (SFX) at free electron lasers (FELs) takes data from billions of randomly oriented microcrystals in femtosecond pulses — enabling room-temperature structures of radiation-sensitive samples and capturing enzyme catalysis at atomic resolution.
Applications
Drug discovery: Structure-based drug design uses X-ray structures of drug-target proteins (kinases, proteases, GPCRs) bound to ligands to guide medicinal chemistry. The HIV protease inhibitor drugs and many cancer kinase inhibitors were developed this way.
Materials science: Crystal structures of semiconductors, superconductors, and battery materials reveal the atomic-level origins of their properties and guide the design of improved materials.
Pharmaceuticals: PXRD identifies polymorphic forms of drugs (different crystal structures with different bioavailability and stability), critical for patent protection and regulatory approval.
Structural biology: The Protein Data Bank (PDB) contains over 200,000 protein and nucleic acid structures, nearly all determined by X-ray crystallography — an incomparable resource for understanding biology at the molecular level.
Geochemistry: Crystal structures of minerals reveal Earth's interior composition and the conditions under which they formed.
X-ray crystallography transforms indirect diffraction data into the most precise three-dimensional structures science can produce — giving chemistry, biology, and materials science their fundamental atomic-resolution view of matter.